Health Care

Healthcare giant Johnson & Johnson (JNJ) kicked off pharma earnings as it posted its first-quarter 2019 earnings on Tuesday, April 16,…

UnitedHealth Group (NYSE:UNH) beat market estimates on both revenue and earnings for the first quarter of 2019, allowing the stock…

Shares of Canadian cannabis company Aphria Inc (NYSE:APHA) fell 8.9% during the pre-market hours on Monday after it reported a…

Aphria Inc. (NYSE: APHA and TSX: APHA) is set to release its financial results for the fiscal third quarter and…

Johnson & Johnson (NYSE: JNJ), one of the first healthcare companies to publish quarterly results this season, will be reporting…

Drugstore chain Rite Aid Corporation (NYSE: RAD) reported a narrower loss from continuing operations in the fourth quarter as it…

In the US, marijuana has been slowly turning to be legal in certain states but it still remained banned at…

Nearly a year after laying out its transformation strategy, with focus on demerging underperforming business units, Novartis (NYSE: NVS) Tuesday…

Viveve Medical Inc. (NASDAQ: VIVE) stock plunged to a 9-year low of $0.58 on Monday. Investors were concerned about the…

Aurora Cannabis Inc. (NYSE: ACB) got a shot in the arm this week after the German authorities granted it approval…

Evoke Pharma Inc. (NASDAQ: EVOK) stock tumbled to over 5-year low of $0.76 on Thursday. Investors remained concerned on the…

Two Israeli firms – InspireMD (NYSE: NSPR) and ReWalk Robotics (NASDAQ: RWLK) – saw their shares fall during the pre-market…

Retailing giant Walgreens Boots Alliance (WBA) posted its second-quarter 2019 earnings before the bell on Tuesday, April 2. For the quarter,…

AngioDynamics (NASDAQ: ANGO) posted third-quarter earnings on Tuesday before the regular trading hours. Net sales for the period increased 3% to…

The planned acquisition of Celgene (CELG) by rival drugmaker Bristol-Myers Squibb (BMY) got a new lease of life this week…

Shares of AstraZeneca Plc (NYSE: AZN) dropped about 6% on NYSE during the pre-market hours and continued to trade in…

Biocept (BIOC) narrowed its loss in the fourth quarter, beating analyst estimates. However, sales failed to impress the street. Shares…

Nasdaq-listed late-stage biotech firm Advaxis, Inc. (NASDAQ:ADXS) focusses on discovery, development, and commercialization of immunotherapy products. The latest from this…

Amarin Corporation (NASDAQ: AMRN) shares got a major boost during the pre-market hours of Thursday after it said the American…

Arcadia Biosciences (RKDA) stock decreased by nearly 2% in the extended hours of trading despite the fourth quarter results surpassed…

Biocept (BIOC) is scheduled to report fourth quarter and full year 2018 results on March 28, Thursday, after the regular…